The Breast Service of the Future is a service transformation project, which aims at combining all elements of excellent cancer care from diagnosis to survivorship. At times of financial and workforce pressures, there should not be any compromise in the quality, efficiency and access to world class cancer care. In addition, cancer services should not only focus on the treatment itself but also on the individual patients and their wellbeing. Breast cancer incidence and biology will be discussed, as well as the reasons why we need to individualize patient diagnosis through imaging and genetics/genomics, through treatments such as radiotherapy and chemotherapy, as well as through personalized surveillance. The role of holistic care will be discussed together with the impact this has on improving patient outcomes.
Dr. Penny Kechagioglou is a senior clinical oncology consultant with extensive experience and a diverse portfolio of clinical strategy, clinical and corporate governance to lead healthcare organisations, realise and manage change. Qualified as a doctor in Wales (UK) and completed an internal medicine residency programme in UK, after which she specialised in Clinical Oncology. Has worked as a consultant clinical oncologist in various UK NHS Trusts and has experienced in managerial roles such as Chief Medical Officer at Genesis Care UK, Clinical Governance Lead for Oncology/ Haematology in the NHS, Vice Chair and member of Research Ethics Committees, NICE Health Technology Assessment Committee member, Specialist advisor for the CQC and the Healthcare Ombudsman. Dr Kechagioglou is a principal investigator and co-investigator in many national and international breast cancer clinical trials and has an extensive medical education portfolio as Senior Clinical Lecturer, Academic mentor, Medical tutor and postgraduate GP Educator. She has completed an MSc in Public Health and an MBA and she is currently working toward a Doctorate in Business Administration.